Squarepoint
CTSO icon

Squarepoint’s Cytosorbents Corp CTSO Stock Holding History

Squarepoint’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,712
Closed -$15K – 4461
2025
Q2 		$15K Sell
11,712
-28,837
-71% -$29K ﹤0.01% 4398
2025
Q1 		$40.5K Buy
+40,549
New +$42.7K ﹤0.01% 4374
2023
Q2 		– Sell
-11,360
Closed -$38.3K – 3633
2023
Q1 		$38.3K Buy
+11,360
New +$34.1K ﹤0.01% 3077
2022
Q1 		– Sell
-14,779
Closed -$62K – 2943
2021
Q4 		$62K Buy
+14,779
New +$82.9K ﹤0.01% 2999
2020
Q3 		– Sell
-84,823
Closed -$840K – 2537
2020
Q2 		$840K Buy
+84,823
New +$779K 0.01% 1041
2020
Q1 		– Sell
-20,047
Closed -$77K – 1982
2019
Q4 		$77K Buy
+20,047
New +$87.4K ﹤0.01% 2366

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's CTSO Position: Q3 2025 in Review

Squarepoint sold out of Cytosorbents Corp (CTSO) in Q3 2025, closing a stake of 11,712 shares — an estimated $15K sold.

Squarepoint first reported a position in CTSO in Q4 2019 and held it in 6 quarters. The position peaked at $840K in Q2 2020. 49 funds tracked by Wall St. Rank hold CTSO as of Q3 2025.

  • Squarepoint reported no remaining Cytosorbents Corp position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 11,712 Cytosorbents Corp shares in Q3 2025, an estimated $15K.
  • Squarepoint first reported a position in Cytosorbents Corp in Q4 2019 and held it in 6 quarters.
  • Squarepoint's Cytosorbents Corp position peaked at $840K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.